Global Nucleic Acids for Molecular Diagnosis Market Growth (Status and Outlook) 2026-2032
The global Nucleic Acids for Molecular Diagnosis market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Nucleic acids for molecular diagnosis refer to the use of DNA or RNA molecules to detect, identify, or quantify specific genetic sequences associated with diseases, pathogens, or other biological conditions. Molecular diagnosis using nucleic acids is a cornerstone of modern diagnostics, offering highly sensitive and specific methods for identifying genetic mutations, infectious agents, and other molecular markers.
United States market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nucleic Acids for Molecular Diagnosis players cover Danaher Corporation, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Nucleic Acids for Molecular Diagnosis Industry Forecast? looks at past sales and reviews total world Nucleic Acids for Molecular Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Nucleic Acids for Molecular Diagnosis sales for 2026 through 2032. With Nucleic Acids for Molecular Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acids for Molecular Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acids for Molecular Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acids for Molecular Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nucleic Acids for Molecular Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acids for Molecular Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acids for Molecular Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acids for Molecular Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
Nucleic acids for molecular diagnosis refer to the use of DNA or RNA molecules to detect, identify, or quantify specific genetic sequences associated with diseases, pathogens, or other biological conditions. Molecular diagnosis using nucleic acids is a cornerstone of modern diagnostics, offering highly sensitive and specific methods for identifying genetic mutations, infectious agents, and other molecular markers.
United States market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Nucleic Acids for Molecular Diagnosis is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Nucleic Acids for Molecular Diagnosis players cover Danaher Corporation, Merck KGaA, Eurofins Scientific SE, Thermo Fisher Scientific Inc., Agilent Technologies, Inc., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the ?Nucleic Acids for Molecular Diagnosis Industry Forecast? looks at past sales and reviews total world Nucleic Acids for Molecular Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Nucleic Acids for Molecular Diagnosis sales for 2026 through 2032. With Nucleic Acids for Molecular Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nucleic Acids for Molecular Diagnosis industry.
This Insight Report provides a comprehensive analysis of the global Nucleic Acids for Molecular Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Nucleic Acids for Molecular Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Nucleic Acids for Molecular Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nucleic Acids for Molecular Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nucleic Acids for Molecular Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acids for Molecular Diagnosis market by product type, application, key players and key regions and countries.
Segmentation by Type:
- DNA Series
- RNA Series
- Infectious Diseases
- Early Cancer Screening
- Blood Screening
- Genetic Diseases
- Genome Sequencing
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Danaher Corporation
- Merck KGaA
- Eurofins Scientific SE
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Kaneka Eurogentec S.A.
- Aji Bio-Pharma
- L.G.C Biosearch Technologies
- Integrated DNA Technologies
- Bio-synthesis Inc.
- metabion
- QIAGEN
- Hongene
- Synthgene
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
2.1.2 Nucleic Acids for Molecular Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Nucleic Acids for Molecular Diagnosis by Country/Region (2021, 2025 & 2032)
2.2 Nucleic Acids for Molecular Diagnosis Segment by Type
2.2.1 DNA Series
2.2.2 RNA Series
2.2.3 Nucleic Acids for Molecular Diagnosis Market Size by Type
2.2.3.1 Nucleic Acids for Molecular Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
2.3 Nucleic Acids for Molecular Diagnosis Segment by Application
2.3.1 Infectious Diseases
2.3.2 Early Cancer Screening
2.3.3 Blood Screening
2.3.4 Genetic Diseases
2.3.5 Genome Sequencing
2.3.6 Other
2.3.7 Nucleic Acids for Molecular Diagnosis Market Size by Application
2.3.7.1 Nucleic Acids for Molecular Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
3 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Nucleic Acids for Molecular Diagnosis Market Size Market Share by Player
3.1.1 Global Nucleic Acids for Molecular Diagnosis Revenue by Player (2021-2026)
3.1.2 Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Player (2021-2026)
3.2 Global Nucleic Acids for Molecular Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS BY REGION
4.1 Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026)
4.2 Global Nucleic Acids for Molecular Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
4.4 APAC Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
4.5 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
5.2 Americas Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
5.3 Americas Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026)
6.2 APAC Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
6.3 APAC Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
7.2 Europe Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
7.3 Europe Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis by Region (2021-2026)
8.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET FORECAST
10.1 Global Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.1.1 Global Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.1.2 Americas Nucleic Acids for Molecular Diagnosis Forecast
10.1.3 APAC Nucleic Acids for Molecular Diagnosis Forecast
10.1.4 Europe Nucleic Acids for Molecular Diagnosis Forecast
10.1.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Forecast
10.2 Americas Nucleic Acids for Molecular Diagnosis Forecast by Country (2027-2032)
10.2.1 United States Market Nucleic Acids for Molecular Diagnosis Forecast
10.2.2 Canada Market Nucleic Acids for Molecular Diagnosis Forecast
10.2.3 Mexico Market Nucleic Acids for Molecular Diagnosis Forecast
10.2.4 Brazil Market Nucleic Acids for Molecular Diagnosis Forecast
10.3 APAC Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.3.1 China Nucleic Acids for Molecular Diagnosis Market Forecast
10.3.2 Japan Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.3 Korea Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.4 Southeast Asia Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.5 India Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.6 Australia Market Nucleic Acids for Molecular Diagnosis Forecast
10.4 Europe Nucleic Acids for Molecular Diagnosis Forecast by Country (2027-2032)
10.4.1 Germany Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.2 France Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.3 UK Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.4 Italy Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.5 Russia Market Nucleic Acids for Molecular Diagnosis Forecast
10.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.5.1 Egypt Market Nucleic Acids for Molecular Diagnosis Forecast
10.5.2 South Africa Market Nucleic Acids for Molecular Diagnosis Forecast
10.5.3 Israel Market Nucleic Acids for Molecular Diagnosis Forecast
10.5.4 Turkey Market Nucleic Acids for Molecular Diagnosis Forecast
10.6 Global Nucleic Acids for Molecular Diagnosis Forecast by Type (2027-2032)
10.7 Global Nucleic Acids for Molecular Diagnosis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Nucleic Acids for Molecular Diagnosis Forecast
11 KEY PLAYERS ANALYSIS
11.1 Danaher Corporation
11.1.1 Danaher Corporation Company Information
11.1.2 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Offered
11.1.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Danaher Corporation Main Business Overview
11.1.5 Danaher Corporation Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Nucleic Acids for Molecular Diagnosis Product Offered
11.2.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Eurofins Scientific SE
11.3.1 Eurofins Scientific SE Company Information
11.3.2 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Offered
11.3.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Eurofins Scientific SE Main Business Overview
11.3.5 Eurofins Scientific SE Latest Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Information
11.4.2 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Offered
11.4.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Information
11.5.2 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Offered
11.5.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Agilent Technologies, Inc. Main Business Overview
11.5.5 Agilent Technologies, Inc. Latest Developments
11.6 Kaneka Eurogentec S.A.
11.6.1 Kaneka Eurogentec S.A. Company Information
11.6.2 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Offered
11.6.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Kaneka Eurogentec S.A. Main Business Overview
11.6.5 Kaneka Eurogentec S.A. Latest Developments
11.7 Aji Bio-Pharma
11.7.1 Aji Bio-Pharma Company Information
11.7.2 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Offered
11.7.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aji Bio-Pharma Main Business Overview
11.7.5 Aji Bio-Pharma Latest Developments
11.8 L.G.C Biosearch Technologies
11.8.1 L.G.C Biosearch Technologies Company Information
11.8.2 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Offered
11.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 L.G.C Biosearch Technologies Main Business Overview
11.8.5 L.G.C Biosearch Technologies Latest Developments
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Information
11.9.2 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Offered
11.9.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Integrated DNA Technologies Main Business Overview
11.9.5 Integrated DNA Technologies Latest Developments
11.10 Bio-synthesis Inc.
11.10.1 Bio-synthesis Inc. Company Information
11.10.2 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Offered
11.10.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bio-synthesis Inc. Main Business Overview
11.10.5 Bio-synthesis Inc. Latest Developments
11.11 metabion
11.11.1 metabion Company Information
11.11.2 metabion Nucleic Acids for Molecular Diagnosis Product Offered
11.11.3 metabion Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 metabion Main Business Overview
11.11.5 metabion Latest Developments
11.12 QIAGEN
11.12.1 QIAGEN Company Information
11.12.2 QIAGEN Nucleic Acids for Molecular Diagnosis Product Offered
11.12.3 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 QIAGEN Main Business Overview
11.12.5 QIAGEN Latest Developments
11.13 Hongene
11.13.1 Hongene Company Information
11.13.2 Hongene Nucleic Acids for Molecular Diagnosis Product Offered
11.13.3 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Hongene Main Business Overview
11.13.5 Hongene Latest Developments
11.14 Synthgene
11.14.1 Synthgene Company Information
11.14.2 Synthgene Nucleic Acids for Molecular Diagnosis Product Offered
11.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Synthgene Main Business Overview
11.14.5 Synthgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Nucleic Acids for Molecular Diagnosis Market Size (2021-2032)
2.1.2 Nucleic Acids for Molecular Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Nucleic Acids for Molecular Diagnosis by Country/Region (2021, 2025 & 2032)
2.2 Nucleic Acids for Molecular Diagnosis Segment by Type
2.2.1 DNA Series
2.2.2 RNA Series
2.2.3 Nucleic Acids for Molecular Diagnosis Market Size by Type
2.2.3.1 Nucleic Acids for Molecular Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.3.2 Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
2.3 Nucleic Acids for Molecular Diagnosis Segment by Application
2.3.1 Infectious Diseases
2.3.2 Early Cancer Screening
2.3.3 Blood Screening
2.3.4 Genetic Diseases
2.3.5 Genome Sequencing
2.3.6 Other
2.3.7 Nucleic Acids for Molecular Diagnosis Market Size by Application
2.3.7.1 Nucleic Acids for Molecular Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.7.2 Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
3 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Nucleic Acids for Molecular Diagnosis Market Size Market Share by Player
3.1.1 Global Nucleic Acids for Molecular Diagnosis Revenue by Player (2021-2026)
3.1.2 Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Player (2021-2026)
3.2 Global Nucleic Acids for Molecular Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS BY REGION
4.1 Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026)
4.2 Global Nucleic Acids for Molecular Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
4.4 APAC Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
4.5 Europe Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
5.2 Americas Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
5.3 Americas Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026)
6.2 APAC Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
6.3 APAC Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026)
7.2 Europe Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
7.3 Europe Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Nucleic Acids for Molecular Diagnosis by Region (2021-2026)
8.2 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL NUCLEIC ACIDS FOR MOLECULAR DIAGNOSIS MARKET FORECAST
10.1 Global Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.1.1 Global Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.1.2 Americas Nucleic Acids for Molecular Diagnosis Forecast
10.1.3 APAC Nucleic Acids for Molecular Diagnosis Forecast
10.1.4 Europe Nucleic Acids for Molecular Diagnosis Forecast
10.1.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Forecast
10.2 Americas Nucleic Acids for Molecular Diagnosis Forecast by Country (2027-2032)
10.2.1 United States Market Nucleic Acids for Molecular Diagnosis Forecast
10.2.2 Canada Market Nucleic Acids for Molecular Diagnosis Forecast
10.2.3 Mexico Market Nucleic Acids for Molecular Diagnosis Forecast
10.2.4 Brazil Market Nucleic Acids for Molecular Diagnosis Forecast
10.3 APAC Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.3.1 China Nucleic Acids for Molecular Diagnosis Market Forecast
10.3.2 Japan Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.3 Korea Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.4 Southeast Asia Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.5 India Market Nucleic Acids for Molecular Diagnosis Forecast
10.3.6 Australia Market Nucleic Acids for Molecular Diagnosis Forecast
10.4 Europe Nucleic Acids for Molecular Diagnosis Forecast by Country (2027-2032)
10.4.1 Germany Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.2 France Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.3 UK Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.4 Italy Market Nucleic Acids for Molecular Diagnosis Forecast
10.4.5 Russia Market Nucleic Acids for Molecular Diagnosis Forecast
10.5 Middle East & Africa Nucleic Acids for Molecular Diagnosis Forecast by Region (2027-2032)
10.5.1 Egypt Market Nucleic Acids for Molecular Diagnosis Forecast
10.5.2 South Africa Market Nucleic Acids for Molecular Diagnosis Forecast
10.5.3 Israel Market Nucleic Acids for Molecular Diagnosis Forecast
10.5.4 Turkey Market Nucleic Acids for Molecular Diagnosis Forecast
10.6 Global Nucleic Acids for Molecular Diagnosis Forecast by Type (2027-2032)
10.7 Global Nucleic Acids for Molecular Diagnosis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Nucleic Acids for Molecular Diagnosis Forecast
11 KEY PLAYERS ANALYSIS
11.1 Danaher Corporation
11.1.1 Danaher Corporation Company Information
11.1.2 Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Offered
11.1.3 Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Danaher Corporation Main Business Overview
11.1.5 Danaher Corporation Latest Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Information
11.2.2 Merck KGaA Nucleic Acids for Molecular Diagnosis Product Offered
11.2.3 Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Merck KGaA Main Business Overview
11.2.5 Merck KGaA Latest Developments
11.3 Eurofins Scientific SE
11.3.1 Eurofins Scientific SE Company Information
11.3.2 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Offered
11.3.3 Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Eurofins Scientific SE Main Business Overview
11.3.5 Eurofins Scientific SE Latest Developments
11.4 Thermo Fisher Scientific Inc.
11.4.1 Thermo Fisher Scientific Inc. Company Information
11.4.2 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Offered
11.4.3 Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Thermo Fisher Scientific Inc. Main Business Overview
11.4.5 Thermo Fisher Scientific Inc. Latest Developments
11.5 Agilent Technologies, Inc.
11.5.1 Agilent Technologies, Inc. Company Information
11.5.2 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Offered
11.5.3 Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Agilent Technologies, Inc. Main Business Overview
11.5.5 Agilent Technologies, Inc. Latest Developments
11.6 Kaneka Eurogentec S.A.
11.6.1 Kaneka Eurogentec S.A. Company Information
11.6.2 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Offered
11.6.3 Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Kaneka Eurogentec S.A. Main Business Overview
11.6.5 Kaneka Eurogentec S.A. Latest Developments
11.7 Aji Bio-Pharma
11.7.1 Aji Bio-Pharma Company Information
11.7.2 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Offered
11.7.3 Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Aji Bio-Pharma Main Business Overview
11.7.5 Aji Bio-Pharma Latest Developments
11.8 L.G.C Biosearch Technologies
11.8.1 L.G.C Biosearch Technologies Company Information
11.8.2 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Offered
11.8.3 L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 L.G.C Biosearch Technologies Main Business Overview
11.8.5 L.G.C Biosearch Technologies Latest Developments
11.9 Integrated DNA Technologies
11.9.1 Integrated DNA Technologies Company Information
11.9.2 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Offered
11.9.3 Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Integrated DNA Technologies Main Business Overview
11.9.5 Integrated DNA Technologies Latest Developments
11.10 Bio-synthesis Inc.
11.10.1 Bio-synthesis Inc. Company Information
11.10.2 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Offered
11.10.3 Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Bio-synthesis Inc. Main Business Overview
11.10.5 Bio-synthesis Inc. Latest Developments
11.11 metabion
11.11.1 metabion Company Information
11.11.2 metabion Nucleic Acids for Molecular Diagnosis Product Offered
11.11.3 metabion Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 metabion Main Business Overview
11.11.5 metabion Latest Developments
11.12 QIAGEN
11.12.1 QIAGEN Company Information
11.12.2 QIAGEN Nucleic Acids for Molecular Diagnosis Product Offered
11.12.3 QIAGEN Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 QIAGEN Main Business Overview
11.12.5 QIAGEN Latest Developments
11.13 Hongene
11.13.1 Hongene Company Information
11.13.2 Hongene Nucleic Acids for Molecular Diagnosis Product Offered
11.13.3 Hongene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Hongene Main Business Overview
11.13.5 Hongene Latest Developments
11.14 Synthgene
11.14.1 Synthgene Company Information
11.14.2 Synthgene Nucleic Acids for Molecular Diagnosis Product Offered
11.14.3 Synthgene Nucleic Acids for Molecular Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Synthgene Main Business Overview
11.14.5 Synthgene Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Nucleic Acids for Molecular Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Nucleic Acids for Molecular Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DNA Series
Table 4. Major Players of RNA Series
Table 5. Nucleic Acids for Molecular Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Table 8. Nucleic Acids for Molecular Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Table 11. Global Nucleic Acids for Molecular Diagnosis Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Player (2021-2026)
Table 13. Nucleic Acids for Molecular Diagnosis Key Players Head office and Products Offered
Table 14. Nucleic Acids for Molecular Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Table 19. Global Nucleic Acids for Molecular Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Nucleic Acids for Molecular Diagnosis Market Size Market Share by Country (2021-2026)
Table 23. Americas Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Table 25. Americas Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Table 27. APAC Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Table 29. APAC Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Country (2021-2026)
Table 33. Europe Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Nucleic Acids for Molecular Diagnosis
Table 39. Key Market Challenges & Risks of Nucleic Acids for Molecular Diagnosis
Table 40. Key Industry Trends of Nucleic Acids for Molecular Diagnosis
Table 41. Global Nucleic Acids for Molecular Diagnosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Nucleic Acids for Molecular Diagnosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Nucleic Acids for Molecular Diagnosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Danaher Corporation Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 46. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Offered
Table 47. Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Danaher Corporation Main Business
Table 49. Danaher Corporation Latest Developments
Table 50. Merck KGaA Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 51. Merck KGaA Nucleic Acids for Molecular Diagnosis Product Offered
Table 52. Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Merck KGaA Main Business
Table 54. Merck KGaA Latest Developments
Table 55. Eurofins Scientific SE Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 56. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Offered
Table 57. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Eurofins Scientific SE Main Business
Table 59. Eurofins Scientific SE Latest Developments
Table 60. Thermo Fisher Scientific Inc. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Offered
Table 62. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Inc. Main Business
Table 64. Thermo Fisher Scientific Inc. Latest Developments
Table 65. Agilent Technologies, Inc. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 66. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Offered
Table 67. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Agilent Technologies, Inc. Main Business
Table 69. Agilent Technologies, Inc. Latest Developments
Table 70. Kaneka Eurogentec S.A. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 71. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Offered
Table 72. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Kaneka Eurogentec S.A. Main Business
Table 74. Kaneka Eurogentec S.A. Latest Developments
Table 75. Aji Bio-Pharma Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 76. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Offered
Table 77. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Aji Bio-Pharma Main Business
Table 79. Aji Bio-Pharma Latest Developments
Table 80. L.G.C Biosearch Technologies Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 81. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Offered
Table 82. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. L.G.C Biosearch Technologies Main Business
Table 84. L.G.C Biosearch Technologies Latest Developments
Table 85. Integrated DNA Technologies Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 86. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Offered
Table 87. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Integrated DNA Technologies Main Business
Table 89. Integrated DNA Technologies Latest Developments
Table 90. Bio-synthesis Inc. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 91. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Offered
Table 92. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Bio-synthesis Inc. Main Business
Table 94. Bio-synthesis Inc. Latest Developments
Table 95. metabion Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 96. metabion Nucleic Acids for Molecular Diagnosis Product Offered
Table 97. metabion Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. metabion Main Business
Table 99. metabion Latest Developments
Table 100. QIAGEN Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 101. QIAGEN Nucleic Acids for Molecular Diagnosis Product Offered
Table 102. QIAGEN Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. QIAGEN Main Business
Table 104. QIAGEN Latest Developments
Table 105. Hongene Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 106. Hongene Nucleic Acids for Molecular Diagnosis Product Offered
Table 107. Hongene Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Hongene Main Business
Table 109. Hongene Latest Developments
Table 110. Synthgene Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 111. Synthgene Nucleic Acids for Molecular Diagnosis Product Offered
Table 112. Synthgene Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Synthgene Main Business
Table 114. Synthgene Latest Developments
Table 1. Nucleic Acids for Molecular Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Nucleic Acids for Molecular Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of DNA Series
Table 4. Major Players of RNA Series
Table 5. Nucleic Acids for Molecular Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 6. Global Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 7. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Table 8. Nucleic Acids for Molecular Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 10. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Table 11. Global Nucleic Acids for Molecular Diagnosis Revenue by Player (2021-2026) & ($ millions)
Table 12. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Player (2021-2026)
Table 13. Nucleic Acids for Molecular Diagnosis Key Players Head office and Products Offered
Table 14. Nucleic Acids for Molecular Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 18. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Table 19. Global Nucleic Acids for Molecular Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 20. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 21. Americas Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 22. Americas Nucleic Acids for Molecular Diagnosis Market Size Market Share by Country (2021-2026)
Table 23. Americas Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 24. Americas Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Table 25. Americas Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 26. Americas Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Table 27. APAC Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 28. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Table 29. APAC Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 30. APAC Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 31. Europe Nucleic Acids for Molecular Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 32. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Country (2021-2026)
Table 33. Europe Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 34. Europe Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 35. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 36. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 37. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Nucleic Acids for Molecular Diagnosis
Table 39. Key Market Challenges & Risks of Nucleic Acids for Molecular Diagnosis
Table 40. Key Industry Trends of Nucleic Acids for Molecular Diagnosis
Table 41. Global Nucleic Acids for Molecular Diagnosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 42. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share Forecast by Region (2027-2032)
Table 43. Global Nucleic Acids for Molecular Diagnosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 44. Global Nucleic Acids for Molecular Diagnosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 45. Danaher Corporation Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 46. Danaher Corporation Nucleic Acids for Molecular Diagnosis Product Offered
Table 47. Danaher Corporation Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 48. Danaher Corporation Main Business
Table 49. Danaher Corporation Latest Developments
Table 50. Merck KGaA Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 51. Merck KGaA Nucleic Acids for Molecular Diagnosis Product Offered
Table 52. Merck KGaA Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 53. Merck KGaA Main Business
Table 54. Merck KGaA Latest Developments
Table 55. Eurofins Scientific SE Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 56. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Product Offered
Table 57. Eurofins Scientific SE Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 58. Eurofins Scientific SE Main Business
Table 59. Eurofins Scientific SE Latest Developments
Table 60. Thermo Fisher Scientific Inc. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 61. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Product Offered
Table 62. Thermo Fisher Scientific Inc. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 63. Thermo Fisher Scientific Inc. Main Business
Table 64. Thermo Fisher Scientific Inc. Latest Developments
Table 65. Agilent Technologies, Inc. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 66. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Product Offered
Table 67. Agilent Technologies, Inc. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 68. Agilent Technologies, Inc. Main Business
Table 69. Agilent Technologies, Inc. Latest Developments
Table 70. Kaneka Eurogentec S.A. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 71. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Product Offered
Table 72. Kaneka Eurogentec S.A. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 73. Kaneka Eurogentec S.A. Main Business
Table 74. Kaneka Eurogentec S.A. Latest Developments
Table 75. Aji Bio-Pharma Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 76. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Product Offered
Table 77. Aji Bio-Pharma Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 78. Aji Bio-Pharma Main Business
Table 79. Aji Bio-Pharma Latest Developments
Table 80. L.G.C Biosearch Technologies Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 81. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Product Offered
Table 82. L.G.C Biosearch Technologies Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 83. L.G.C Biosearch Technologies Main Business
Table 84. L.G.C Biosearch Technologies Latest Developments
Table 85. Integrated DNA Technologies Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 86. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Product Offered
Table 87. Integrated DNA Technologies Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 88. Integrated DNA Technologies Main Business
Table 89. Integrated DNA Technologies Latest Developments
Table 90. Bio-synthesis Inc. Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 91. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Product Offered
Table 92. Bio-synthesis Inc. Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 93. Bio-synthesis Inc. Main Business
Table 94. Bio-synthesis Inc. Latest Developments
Table 95. metabion Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 96. metabion Nucleic Acids for Molecular Diagnosis Product Offered
Table 97. metabion Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 98. metabion Main Business
Table 99. metabion Latest Developments
Table 100. QIAGEN Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 101. QIAGEN Nucleic Acids for Molecular Diagnosis Product Offered
Table 102. QIAGEN Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 103. QIAGEN Main Business
Table 104. QIAGEN Latest Developments
Table 105. Hongene Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 106. Hongene Nucleic Acids for Molecular Diagnosis Product Offered
Table 107. Hongene Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 108. Hongene Main Business
Table 109. Hongene Latest Developments
Table 110. Synthgene Details, Company Type, Nucleic Acids for Molecular Diagnosis Area Served and Its Competitors
Table 111. Synthgene Nucleic Acids for Molecular Diagnosis Product Offered
Table 112. Synthgene Nucleic Acids for Molecular Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 113. Synthgene Main Business
Table 114. Synthgene Latest Developments
LIST OF FIGURES
Figure 1. Nucleic Acids for Molecular Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Nucleic Acids for Molecular Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Nucleic Acids for Molecular Diagnosis Sales Market Share by Country/Region (2025)
Figure 8. Nucleic Acids for Molecular Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type in 2025
Figure 10. Nucleic Acids for Molecular Diagnosis in Infectious Diseases
Figure 11. Global Nucleic Acids for Molecular Diagnosis Market: Infectious Diseases (2021-2026) & ($ millions)
Figure 12. Nucleic Acids for Molecular Diagnosis in Early Cancer Screening
Figure 13. Global Nucleic Acids for Molecular Diagnosis Market: Early Cancer Screening (2021-2026) & ($ millions)
Figure 14. Nucleic Acids for Molecular Diagnosis in Blood Screening
Figure 15. Global Nucleic Acids for Molecular Diagnosis Market: Blood Screening (2021-2026) & ($ millions)
Figure 16. Nucleic Acids for Molecular Diagnosis in Genetic Diseases
Figure 17. Global Nucleic Acids for Molecular Diagnosis Market: Genetic Diseases (2021-2026) & ($ millions)
Figure 18. Nucleic Acids for Molecular Diagnosis in Genome Sequencing
Figure 19. Global Nucleic Acids for Molecular Diagnosis Market: Genome Sequencing (2021-2026) & ($ millions)
Figure 20. Nucleic Acids for Molecular Diagnosis in Other
Figure 21. Global Nucleic Acids for Molecular Diagnosis Market: Other (2021-2026) & ($ millions)
Figure 22. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application in 2025
Figure 23. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Player in 2025
Figure 24. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Figure 25. Americas Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 26. APAC Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 27. Europe Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 29. Americas Nucleic Acids for Molecular Diagnosis Value Market Share by Country in 2025
Figure 30. United States Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region in 2025
Figure 35. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Figure 36. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Figure 37. China Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 41. India Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Country in 2025
Figure 44. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Figure 45. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Figure 46. Germany Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 47. France Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 60. APAC Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 61. Europe Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 63. United States Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 64. Canada Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 65. Mexico Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 66. Brazil Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 67. China Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 68. Japan Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 69. Korea Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 71. India Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 72. Australia Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 73. Germany Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 74. France Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 75. UK Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 76. Italy Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 77. Russia Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 78. Egypt Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 79. South Africa Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 80. Israel Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 81. Turkey Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 82. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 1. Nucleic Acids for Molecular Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nucleic Acids for Molecular Diagnosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Nucleic Acids for Molecular Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Nucleic Acids for Molecular Diagnosis Sales Market Share by Country/Region (2025)
Figure 8. Nucleic Acids for Molecular Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type in 2025
Figure 10. Nucleic Acids for Molecular Diagnosis in Infectious Diseases
Figure 11. Global Nucleic Acids for Molecular Diagnosis Market: Infectious Diseases (2021-2026) & ($ millions)
Figure 12. Nucleic Acids for Molecular Diagnosis in Early Cancer Screening
Figure 13. Global Nucleic Acids for Molecular Diagnosis Market: Early Cancer Screening (2021-2026) & ($ millions)
Figure 14. Nucleic Acids for Molecular Diagnosis in Blood Screening
Figure 15. Global Nucleic Acids for Molecular Diagnosis Market: Blood Screening (2021-2026) & ($ millions)
Figure 16. Nucleic Acids for Molecular Diagnosis in Genetic Diseases
Figure 17. Global Nucleic Acids for Molecular Diagnosis Market: Genetic Diseases (2021-2026) & ($ millions)
Figure 18. Nucleic Acids for Molecular Diagnosis in Genome Sequencing
Figure 19. Global Nucleic Acids for Molecular Diagnosis Market: Genome Sequencing (2021-2026) & ($ millions)
Figure 20. Nucleic Acids for Molecular Diagnosis in Other
Figure 21. Global Nucleic Acids for Molecular Diagnosis Market: Other (2021-2026) & ($ millions)
Figure 22. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application in 2025
Figure 23. Global Nucleic Acids for Molecular Diagnosis Revenue Market Share by Player in 2025
Figure 24. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Figure 25. Americas Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 26. APAC Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 27. Europe Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 28. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size 2021-2026 ($ millions)
Figure 29. Americas Nucleic Acids for Molecular Diagnosis Value Market Share by Country in 2025
Figure 30. United States Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 31. Canada Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 32. Mexico Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 33. Brazil Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 34. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region in 2025
Figure 35. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Figure 36. APAC Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Figure 37. China Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 38. Japan Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 39. South Korea Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 40. Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 41. India Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 42. Australia Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Country in 2025
Figure 44. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Figure 45. Europe Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Figure 46. Germany Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 47. France Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 48. UK Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 49. Italy Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Russia Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 51. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Market Share by Region (2021-2026)
Figure 52. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Market Share by Type (2021-2026)
Figure 53. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size Market Share by Application (2021-2026)
Figure 54. Egypt Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 55. South Africa Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 56. Israel Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 57. Turkey Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 58. GCC Countries Nucleic Acids for Molecular Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 59. Americas Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 60. APAC Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 61. Europe Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 62. Middle East & Africa Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 63. United States Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 64. Canada Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 65. Mexico Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 66. Brazil Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 67. China Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 68. Japan Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 69. Korea Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 70. Southeast Asia Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 71. India Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 72. Australia Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 73. Germany Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 74. France Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 75. UK Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 76. Italy Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 77. Russia Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 78. Egypt Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 79. South Africa Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 80. Israel Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 81. Turkey Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
Figure 82. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share Forecast by Type (2027-2032)
Figure 83. Global Nucleic Acids for Molecular Diagnosis Market Size Market Share Forecast by Application (2027-2032)
Figure 84. GCC Countries Nucleic Acids for Molecular Diagnosis Market Size 2027-2032 ($ millions)
